OHT or suspected COAG with high IOP treat based on estimated risk of conversion to COAG:
Central corneal thickness
>590 micrometers
555-590 micrometers
<555 micrometers
Any
Untreated IOP (mm Hg)
>21-25
>25-32
>21-25
>25-32
>21-25
>25-32
> 32
Age
Any
Any
Any
Treat till 60
Treat till 65
Treat till 80
Any
Treatment
No treatment
No treatment
No treatment
BB
PGA
PGA
PGA
BB: Beta blockers (if contra-indicated offer PGA)
PGA: prostaglandin analogue
Do not treat people with suspected COAG and normal IOP
Offer alternative pharmacological treatment (a prostaglandin analogue, betablocker, carbonic anhydrase inhibitor or sympathomimetic, whose IOP cannot be reduced sufficiently to prevent sight loss or are intolerant or newly diagnosed and moderate COAG
COAG and IOP not reduced sufficiently to prevent risk of sight loss despite pharmacological treatment, offer:
Laser trabeculoplasty
Surgery with pharmacological augmentation (MMC or 5-FU[4]) as indicated